Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December https://ift.tt/o9XGaF1

The CEO said he expects wide coverage for the drug from pharmacy benefit managers (PBMs) and that at least one major PBM will start recommending coverage of the drug for its clients this year. But he cautioned that employers choosing not to cover weight loss drugs for their health plans would be a constraint on demand.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/bPU3ugr
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.